NXTC NextCure, Inc.: institutional ownership and insider trading
31 funds reported holding $4.09M of NextCure, Inc. in their latest 13F filings; in Q2 2026 funds net sold $413K, with 13 new positions and 7 funds selling out; over the last 12 months insiders bought $1.71M and sold $185K on the open market.
Famous investors holding NXTC
- Renaissance Technologies (Renaissance Technologies): $274K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $141K, 0.0% of the portfolio
Largest institutional holders of NXTC
- VANGUARD GROUP INC — $1.30M
- Ikarian Capital, LLC — $461K
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $444K
- Sofinnova Investments, Inc. — $356K
- RENAISSANCE TECHNOLOGIES LLC — $274K
- VANGUARD CAPITAL MANAGEMENT LLC — $251K
- MILLENNIUM MANAGEMENT LLC — $141K
- BOOTHBAY FUND MANAGEMENT, LLC — $135K
- Squadron Capital Management LLC — $103K
- Verdad Advisers, LP — $96.7K
Recent NXTC insider trades
- Aug 10, 2026: Ren Jinsheng sold 30,000 shares ($185K)
- Jul 31, 2026: Schneeberger Daniel bought 329,153 shares ($1.62M)
- Jul 29, 2026: Schneeberger Daniel bought 17,608 shares ($87.7K)
5%+ owners
- ADAR1 Capital Management, LLC: 15.8% (Schedule 13G, filed Aug 14, 2026)
- Ikarian Capital, LLC: 10.0% (Schedule 13G/A, filed Aug 14, 2026)
- JP Sailing Capital Ltd: 9.9% (Schedule 13G, filed Oct 20, 2026)
- Simcere Zaiming, Inc.: 9.4% (Schedule 13G/A, filed May 6, 2026)
- Adage Capital Management, L.P.: 7.7% (Schedule 13G, filed Aug 12, 2026)
- Affinity Asset Advisors, LLC: 6.4% (Schedule 13G/A, filed Aug 13, 2026)